Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -1414.57% is 411% below its 5-year average of -277.02%, around the middle of its 5-year range (-2435.93%–188.99%).
18.20% below its 12-month average of -1196.80%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1485.21%.
NET PROFIT MARGIN
-1414.57%
NET PROFIT MARGIN AVG TTM
-1196.80%
NET PROFIT MARGIN AVG 3Y
-348.48%
NET PROFIT MARGIN AVG 5Y
-277.02%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-18.20%
CURRENT VS 3Y AVG
-305.92%
CURRENT VS 5Y AVG
-410.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.04%
median of 850 covered companies
CURRENT VS SECTOR MEDIAN
-3536325.00%
vs the sector median at left
Scilex Holding Company
Market Cap
$32.82M
Net Profit Margin
-1414.57%
TTM Avg
-1196.80%
3Y Avg
-348.48%
5Y Avg
-277.02%
Market Cap
$33.26M
Net Profit Margin
-241.01%
TTM Avg
-2216.37%
3Y Avg
-1421.99%
5Y Avg
-1438.67%
Market Cap
$32.68M
Net Profit Margin
-7.33%
TTM Avg
-4.07%
3Y Avg
-10.97%
5Y Avg
-24.38%
Market Cap
$34.21M
Net Profit Margin
-12.24%
TTM Avg
-6.29%
3Y Avg
-4.54%
5Y Avg
-3.49%
Market Cap
$34.48M
Net Profit Margin
426.93%
TTM Avg
106.45%
3Y Avg
-19.31%
5Y Avg
-30.13%
Market Cap
$31.44M
Net Profit Margin
0.83%
TTM Avg
-0.61%
3Y Avg
1.30%
5Y Avg
1.65%
Market Cap
$34.42M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1673.30%
Market Cap
$30.33M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-615.82%
5Y Avg
-6847.94%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scilex Holding Company (SCLX) | $32.82M | -1414.57% | -1196.80% | -348.48% | -277.02% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.26M | -241.01% | -2216.37% | -1421.99% | -1438.67% |
| Rockwell Medical, Inc. (RMTI)vs › | $32.68M | -7.33% | -4.07% | -10.97% | -24.38% |
| HeartBeam, Inc. (BEAT)vs › | $33.59M | 0.00% | 0.00% | 0.00% | 0.00% |
| Accuray Incorporated (ARAY)vs › | $34.21M | -12.24% | -6.29% | -4.54% | -3.49% |
| Elutia Inc (ELUT)vs › | $34.48M | 426.93% | 106.45% | -19.31% | -30.13% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 0.83% | -0.61% | 1.30% | 1.65% |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.42M | 0.00% | 0.00% | 0.00% | -1673.30% |
| BeyondSpring Inc. (BYSI)vs › | $30.33M | 0.00% | 0.00% | -615.82% | -6847.94% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $30.85M | -121.04% | -43.71% | -4.52% | 10.54% |
Operating Margin
-903.5%
Net Profit Margin
-1414.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -1485.21% |
| 2026-03-31 | -502.38% |
| 2025-12-31 | -690.84% |
| 2025-09-30 | -2435.93% |
| 2025-06-30 | -869.65% |
| 2025-03-31 | -521.18% |
| 2024-12-31 | -43.36% |
| 2024-09-30 | -30.40% |
| 2024-06-30 | -229.58% |
| 2024-03-31 | -223.97% |
| 2023-12-31 | -158.97% |
| 2023-09-30 | -351.18% |
| 2023-06-30 | -211.80% |
| 2023-03-31 | -290.62% |
| 2022-12-31 | -150.05% |
| 2022-09-30 | 188.99% |
| 2022-06-30 | -225.06% |
| 2022-03-31 | -134.22% |
| 2021-12-31 | -507.87% |
| 2021-09-30 | -144.42% |
| 2021-06-30 | -166.80% |
| 2021-03-31 | -345.64% |
| 2020-12-31 | -201.69% |
| 2020-09-30 | -201.69% |
| 2020-06-30 | -201.69% |
| 2020-03-31 | -201.69% |
| 2019-12-31 | -849.11% |
| 2019-09-30 | -849.11% |
| 2019-06-30 | -849.11% |
| 2019-03-31 | -849.11% |
